Semaglutide Effectiveness in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease in the Real World Practice
Clinical trial NCT06983171 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06983171
- Sponsor
- Center of target therapy
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-04-02
- Primary completion
- 2028-09-12
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.